Muscle Wasting Disorders Market Size to Exceed $29.67 Billion by 2029 | Growth and Industry Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Muscle Wasting Disorders Market Grown from 2024 to 2025?#_x000D_
The market for muscle wasting disorders has seen swift growth in recent times. Its size is forecasted to escalate from $15.06 billion in 2024 to $17.54 billion in 2025, with a compound annual growth rate (CAGR) of 16.5%. Factors contributing to the growth during the historic period include a surge in the elderly population, an uptick in chronic disease cases, progress in research and development, heightened consciousness about early detection, and the emergence of new therapeutic strategies._x000D_
_x000D_
#What Growth Rate Is Anticipated for the Muscle Wasting Disorders Market in the Coming Years?#_x000D_
In the forthcoming years, the muscle wasting disorders market is projected to experience a swift expansion, reaching a value of $29.67 billion by 2029, registering a compound annual growth rate (CAGR) of 14.1%. Regulatory backing, patient support initiatives, enhancements in healthcare infrastructure, globalization of clinical examinations, and personal treatment methodologies are factors attributing to the growth during this forecast period. The market’s advancement during this period is anticipated to be shaped by multiple trends including the integration of telemedicine, technological progression in diagnostic procedures, product evolution, increased collaborations and strategic partnerships, advances in therapeutic areas, research into molecular structures, and biopharmaceutical innovations._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp_x000D_
_x000D_
#Who Are the Leading Companies in the Muscle Wasting Disorders Market?#_x000D_
Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc._x000D_
_x000D_
#What Are the Key Drivers of the Muscle Wasting Disorders Market?#_x000D_
The anticipated enhancement in the muscle wasting disorders market is influenced by the rising inclination towards a sedentary lifestyle. This lifestyle reflects physical inactivity or minimal participation in physical exercise. Negative effects on muscle functioning due to sedentary behavior can result in reduced muscle strength and stamina, catalyzing the occurrence of muscle wasting disorders. It consequently becomes challenging for individuals to conserve their muscle mass and functionality. For instance, the World Health Organization, an intergovernmental organization based in Switzerland, reported in 2022 that over 80% of young people and 27% of adults failed to meet the physical activity levels it recommends. Hence, the muscle wasting disorders market’s progression is propelled by the increasing adoption of a sedentary lifestyle._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=13706&type=smp_x000D_
_x000D_
#What Are the Key Market Segments in the Muscle Wasting Disorders Industry?#_x000D_
The muscle wasting disorders market covered in this report is segmented –_x000D_
_x000D_
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types_x000D_
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types_x000D_
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents_x000D_
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs_x000D_
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements_x000D_
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions_x000D_
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques_x000D_
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices_x000D_
_x000D_
_x000D_
#What Are the Latest Trends in the Muscle Wasting Disorders Market?#_x000D_
Key players in the muscle wasting disorders market are focusing on the creation of innovative products such as unique gene therapies in order to improve patient treatment for these disorders. The term ‘unique gene therapy’ refers to a form of medical intervention that is designed to generate curative effects by modifying gene expressions or changing the biological functions of live cells. For example, Sarepta Therapeutics, a biotechnology company based in the US, launched Elevidys in June 2023. Elevidys, the first gene therapy approved by the US Food and Drug Administration (FDA) for treating Duchenne muscular dystrophy (DMD) in children aged between 4 and 5, is a recombinant gene therapy. Its purpose is to infuse a gene into the body that results in a truncated protein encompassing specific domains of the normal muscle cell’s dystrophin protein. Elevidys is delivered via a single intravenous infusion._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
_x000D_
#What Are the Key Regional Markets in the Muscle Wasting Disorders Industry?#_x000D_
North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13706_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the muscle wasting disorders market, and how is it changing globally?_x000D_
2. Who are the major companies in the muscle wasting disorders market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the muscle wasting disorders market right now?_x000D_
4. Which products or customer segments are growing the most in the muscle wasting disorders market?_x000D_
5. What factors are helping or slowing down the growth of the muscle wasting disorders market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 2071930708_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
